Education
About Us
Working with TipRanks
Follow Us
Precision Optics Corporation (POCI)
NASDAQ:POCI
POCI Stock Chart & Stats
$4.22
-$0.09(-1.91%)
At close: 4:00 PM EST
$4.22
-$0.09(-1.91%)
Day’s Range― - ―
52-Week Range$3.77 - $5.34
Previous CloseN/A
Volume150.00
Average Volume (3M)22.99K
Market Cap
$32.40M
Enterprise Value$36.69M
Total Cash (Recent Filing)$1.39M
Total Debt (Recent Filing)$3.38M
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Feb 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding7,714,701
10 Day Avg. Volume30,022
30 Day Avg. Volume22,992
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)2.71
Price to Sales (P/S)1.74
P/FCF Ratio-8.82
Enterprise Value/Market Cap1.13
Enterprise Value/Revenue1.70
Enterprise Value/Gross Profit11.35
Enterprise Value/Ebitda-6.47
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Precision Optics Corporation News
POCI FAQ
What was Precision Optics Corporation’s price range in the past 12 months?
Precision Optics Corporation lowest stock price was $3.77 and its highest was $5.34 in the past 12 months.
What is Precision Optics Corporation’s market cap?
Precision Optics Corporation’s market cap is $32.40M.
When is Precision Optics Corporation’s upcoming earnings report date?
Precision Optics Corporation’s upcoming earnings report date is Feb 12, 2026 which is in 56 days.
How were Precision Optics Corporation’s earnings last quarter?
Precision Optics Corporation released its earnings results on Nov 13, 2025. The company reported -$0.212 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.212.
Is Precision Optics Corporation overvalued?
According to Wall Street analysts Precision Optics Corporation’s price is currently Overvalued.
Does Precision Optics Corporation pay dividends?
Precision Optics Corporation does not currently pay dividends.
What is Precision Optics Corporation’s EPS estimate?
Precision Optics Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Precision Optics Corporation have?
Precision Optics Corporation has 7,714,701 shares outstanding.
What happened to Precision Optics Corporation’s price movement after its last earnings report?
Precision Optics Corporation reported an EPS of -$0.212 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.559%.
Which hedge fund is a major shareholder of Precision Optics Corporation?
Currently, no hedge funds are holding shares in POCI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Precision Optics Corporation Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.78%
12-Months-Change
Fundamentals
Return on Equity
-57.98%
Trailing 12-Months
Asset Growth
29.85%
Trailing 12-Months
Company Description
Precision Optics Corporation
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
POCI Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented significant revenue growth and new development agreements, indicating strong market demand and strategic expansion. However, challenges with gross margins and a net loss slightly offset the positive momentum. The company is optimistic about future profitability and growth.View all POCI earnings summariesTechnical Analysis
Retractable Technologies
―
Milestone Scientific
―
Femasys
―
NexGel Inc
―
Meihua International Medical Technologies Co., Ltd.
―
Ownership Overview
8.30% Insiders
12.57% Mutual Funds
15.70% Other Institutional Investors
60.71% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---